Century Therapeutics Q1 2024 GAAP EPS $(0.45) Beats $(0.52) Estimate, Sales $855.000K Miss $1.262M Estimate
Author: Benzinga Newsdesk | May 09, 2024 07:58am
Century Therapeutics (NASDAQ:
IPSC) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.52) by 13.46 percent. This is a 15.09 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $855.000 thousand which missed the analyst consensus estimate of $1.262 million by 32.25 percent. This is a 50.29 percent decrease over sales of $1.720 million the same period last year.
Posted In: IPSC